Hutchmed begins phase-three trials of lymphoma therapy in China
(Alliance News) - Hutchmed China Ltd on Monday said it had begun phase-three clinical trials of its lymphoma treatment in China. Read More
| Price | 203.00p on 28-04-2026 at 14:31:37 |
|---|---|
| Change | 4.50p 2.27% |
| Buy | 203.00p |
| Sell | 195.50p |
| Last Trade: | Sell 985.00 at 202.626p |
| Day's Volume: | 10,589 |
| Last Close: | 198.50p |
| Open: | 195.50p |
| ISIN: | KYG4672N1198 |
| Day's Range | 195.50p - 203.00p |
| 52wk Range: | 192.00p - 292.00p |
| Market Capitalisation: | £1.75b |
| VWAP: | 200.88383p |
| Shares in Issue: | 859.74m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 985 | 202.626p | Negotiated Trade |
13:43:46 - 28-Apr-26 |
| Sell* | 1 | 195.50p | SI Trade |
10:20:36 - 28-Apr-26 |
| Sell* | 1,000 | 203.00p | Automatic Execution |
09:07:59 - 28-Apr-26 |
| Sell* | 1,000 | 203.00p | Automatic Execution |
09:07:59 - 28-Apr-26 |
| Sell* | 745 | 203.00p | Automatic Execution |
09:07:59 - 28-Apr-26 |
| Sell* | 1,000 | 203.00p | Automatic Execution |
09:07:59 - 28-Apr-26 |
| Sell* | 75 | 203.00p | Automatic Execution |
09:07:58 - 28-Apr-26 |
| Buy* | 1,180 | 202.00p | Automatic Execution |
09:07:58 - 28-Apr-26 |
| Unknown* | 0 | 202.00p | SI Trade |
08:43:54 - 28-Apr-26 |
| Buy* | 2,000 | 200.4445p | Ordinary |
08:31:31 - 28-Apr-26 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 9:30 am | RNS | 2025 Annual Report and Notice of AGM |
| 9th Apr 2026 7:00 am | RNS-R | Data to be Presented at AACR Annual Meeting 2026 |
| 23rd Mar 2026 7:00 am | RNS-R | HUTCHMED Initiates Phase III Trial of HMPL-760 |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 9th Mar 2026 9:30 am | RNS | Update on Licensed Oncology Product in China |
| 6th Mar 2026 8:30 am | RNS | Directorate change |
| 5th Mar 2026 1:00 pm | RNS-R | Publication of Form 20-F |